Company Data
Autolus Therapeutics plc
Ticker
AUTL
Current Price
$1.5 -4.46%
Market Cap
$399.2M
Price Target
Refer to Report
Volume
2.1M
52wk Range
$1.105 - $5
Overview
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer. The company’s clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.